50 results
F-1
EX-10.4
LEGN
Legend Biotech Corp
13 May 20
Registration statement (foreign)
4:41pm
.
Long-term Incentive Plan:
You will be eligible to participate in Legend Biotech share option plan, which is a performance-based incentive plan. You … will be automatically enrolled in Accidental Death and Dismemberment, Long Term Disability and life Insurance. You will also be eligible
6-K
LEGN
Legend Biotech Corp
21 Apr 23
Legend Biotech Corporation 6-K
8:30am
results: Phase 1b/2 study of ciltacabtagene autoleucel in heavily pretreated patients with relapsed/refractory multiple myeloma”
“Long-term remission … “Long-term remission and survival in patients with relapsed or refractory multiple myeloma after treatment of LCAR-B38M CAR-T – at least 5-year follow-up
6-K
EX-10.1
LEGN
Legend Biotech Corp
30 Dec 20
Current report (foreign)
6:50am
on your performance rating.
Long-Term Incentive Plan:
Following your acceptance of this offer and subject to approval by the Company’s Board, each … of the applicable plans. You will also be eligible to receive accidental death and dismemberment, long-term disability and life insurance, subject
6-K
LEGN
Legend Biotech Corp
21 Dec 23
Current report (foreign)
4:15pm
of the RSU Grant is linked to and contingent upon achievement of the Company’s key long-term goals, the Company’s Board believes that the RSU Grant
6-K
EX-99.1
LEGN
Legend Biotech Corp
18 May 23
Legend Biotech Corporation 6-K
8:30am
our deepest gratitude to our investors for their overwhelming support and confidence in our company’s mission and remain committed to creating long-term value … LIABILITIES
Collaboration interest-bearing advanced funding
Lease liabilities long term
Government grants
Other non-current liabilities
Total non
6-K
EX-99.1
hkxo r4e4uh3v2
15 Aug 23
Legend Biotech Reports Second Quarter 2023 Results and Recent Highlights
6:10am
6-K
EX-99.2
jvh q3pdu7jz77dzjvp2
21 Apr 23
Legend Biotech Corporation 6-K
8:30am
6-K
EX-99.1
qv1c sw9vb6si
4 Aug 22
Legend Biotech Appoints Three New Directors and Elects New Chairman of the Board
4:18pm
6-K
EX-99.1
m60ffct6p02yn
3 Apr 23
Legend Biotech 6-K
4:01pm
6-K
EX-99.1
hng2ouz6pi4pnk
9 May 22
Legend Biotech Corporation 6-K
6:32am
F-1/A
EX-10.7
ean4p6dwoshzylfly5o
29 May 20
Registration statement (foreign) (amended)
8:32am
S-8
EX-10.2
51833mw5 ly0ulxse2w
26 Jun 20
Registration of securities for employees
4:11pm
S-8 POS
EX-10.2
xinocgpci ynsqxnua5x
4 Sep 20
Registration of securities for employees (post-effective amendment)
4:19pm
6-K
EX-99.1
v215aw7j7hf vn
16 May 23
Legend Biotech Corporation 6-K
8:39am
6-K
EX-99.1
xp3mjn4ije
13 May 24
Legend Biotech Reports First Quarter 2024 Results and Recent Highlights
7:01am
6-K
EX-99.1
rjrg1
5 Jun 23
Legend Biotech 6-K
11:17am
6-K
EX-99.1
sk3 83r7na0dy
30 Mar 23
Legend Biotech Corporation 6-K
4:01pm
6-K
EX-99.1
tornb34zzjpoil mks
11 Mar 24
Legend Biotech Reports Fourth Quarter and Full Year 2023 Results and Recent Highlights
7:52am
6-K
p8tryv256kgim1fd
15 Aug 23
Legend Biotech Reports Second Quarter 2023 Results and Recent Highlights
6:10am
6-K
EX-99.1
k9e rj86c2c
9 Jan 24
Legend Biotech Corporation 6-K
4:01pm